ERBB2 and Obesity: Another comorbidity, such as obesity, hampers the survival of residual tumor cells in a HER2+ BRCA model (Ecker et al., 2019), which may support the idea that obesity has a negative impact on the response to chemotherapy, where the A2A receptor could have a key role.